The article focuses on the trends and opportunities for biotech in territories outside the U.S. and Europe. According to a report, Australia, Israel, China and India has joined the line as largest biotech sectors in the world aside from the U.S. and Europe. Another key trend in the industry has been the shift of professionals into biotech. There is also an increasing opportunity for a commercial success by applying a private equity style of investment management in private capital for mid-stage Australian life science companies.